Accu Primary Immunodeficiency Panel Test

Accu Primary Immunodeficiency Panel Test

The Primary Immunodeficiency Panel Test is a diagnostic test that evaluates genetic mutations associated with immune system deficiencies, helping to diagnose inherited disorders affecting immune function. GDX Lab analyzes 471 genes to further enhance the detection capabilities for these genetic abnormalities.

Accu BRCA1 / BRCA2 Test

Accu BRCA1 / BRCA2 Test

At GDX Lab, BRCA1 and BRCA2 genetic tests use next-generation sequencing to detect mutations associated with higher risks of breast, ovarian, and other cancers. This method ensures precise identification of critical mutations, aiding healthcare professionals in personalized cancer risk assessment and treatment planning for patients.

Accu Urinary Tract Infection (UTI) Panel test

Accu Urinary Tract Infection (UTI) Panel test

Test urine for bacteria and fungi that may be causing UTI, IC, bladder infection, and other urogenital issues. More likely to detect infection than standard lab tests by leveraging the power of Next Generation Sequencing.

Accu Comprehensive Cancer Panel Test

Accu Comprehensive Cancer Panel Test

The Comprehensive Cancer Panel Test is a diagnostic tool that examines numerous genes to detect genetic mutations linked to different cancer types, facilitating personalized treatment strategies and prognosis evaluation. GDX Lab analyzes 154 genes in its Comprehensive Cancer Panel, ensuring comprehensive assessment of genetic changes that impact cancer development and treatment responses.

Microbiome Test Gut Morning

Microbiome Test Gut Morning

We use a stool sample to perform a comprehensive gut microbiome test, analyzing your gut flora to provide insights into your gut health and guide better dietary choices. For GI tract health concerns, consult a healthcare provider. Get a gut microbiome test at GDx lab to proactively improve your gut health.

Accu PGx (Pharmacogenomics) Test

Accu PGx (Pharmacogenomics) Test

Pharmacogenetics testing analyzes specific genes to predict how individuals will respond to medications, helping healthcare providers tailor treatment plans. GDX Lab's platform examines 44 target genes, ensuring a comprehensive assessment of genetic variations impacting drug metabolism, transport, and receptor interactions, thus optimizing medication efficacy and minimizing adverse effects.

장내미생물 소식

Address 770 West Hampden Avenue, Suite 125, Englewood, Colorado 80110, United States

Phone +1-720-255-2280

Email info@gdxlab.com

CLIA # 06D2241792

Hours  Monday – Friday 9am – 5pm  

                Saturday – Sunday closed

line

ⓒGDXLAB. All Right Reserved.